Laporan Laba Rugi (TTM)
Laporan Laba Rugi Medeze Group Public Company Limited - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 12-31 |
2021 12-31 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 407 | 464 | 612 | 658 | 673 | 682 | 707 | 720 | 780 | 823 | 874 | 899 | 875 |
| Change (%) | 14.01 | 31.81 | 7.53 | 2.31 | 1.27 | 3.74 | 1.84 | 8.28 | 5.56 | 6.18 | 2.85 | -2.68 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 136 | 126 | 129 | 135 | 138 | 146 | 152 | 157 | 167 | 173 | 181 | 185 | 188 |
| Change (%) | -7.48 | 2.06 | 4.79 | 2.17 | 6.10 | 3.72 | 3.75 | 6.32 | 3.53 | 4.51 | 2.41 | 1.45 | |
| % of Revenue | 33.45 | 27.15 | 21.02 | 20.49 | 20.46 | 21.43 | 21.43 | 21.83 | 21.44 | 21.03 | 20.69 | 20.61 | 21.48 |
| Gross Operating Profit | 271 | 338 | 483 | 523 | 536 | 536 | 556 | 563 | 613 | 650 | 693 | 714 | 687 |
| Change (%) | 24.81 | 42.89 | 8.27 | 2.35 | 0.02 | 3.75 | 1.32 | 8.83 | 6.11 | 6.63 | 2.97 | -3.75 | |
| % of Revenue | 66.55 | 72.85 | 78.98 | 79.51 | 79.54 | 78.57 | 78.57 | 78.17 | 78.56 | 78.97 | 79.31 | 79.39 | 78.52 |
| SG&A | 163 | 169 | 217 | 227 | 244 | 243 | 236 | 253 | 258 | 293 | 316 | 325 | 344 |
| Change (%) | 3.86 | 27.91 | 4.63 | 7.59 | -0.24 | -3.09 | 7.43 | 1.90 | 13.38 | 7.91 | 2.96 | 5.70 | |
| % of Revenue | 40.05 | 36.48 | 35.40 | 34.44 | 36.22 | 35.68 | 33.33 | 35.15 | 33.08 | 35.53 | 36.11 | 36.15 | 39.26 |
| R&D | 1 | 1 | 1 | 16 | 19 | 23 | 26 | 13 | 13 | 13 | |||
| Change (%) | 0.00 | 1,116.50 | 21.55 | 21.67 | 12.74 | -48.48 | -3.18 | 1.20 | |||||
| % of Revenue | 0.21 | 0.19 | 0.19 | 2.22 | 2.64 | 2.97 | 3.17 | 1.54 | 1.45 | 1.51 | |||
| OpEx | 299 | 295 | 347 | 361 | 383 | 391 | 403 | 430 | 448 | 492 | 510 | 523 | 545 |
| Change (%) | -1.30 | 17.32 | 4.30 | 5.92 | 2.04 | 3.15 | 6.59 | 4.39 | 9.67 | 3.72 | 2.60 | 4.08 | |
| % of Revenue | 73.50 | 63.63 | 56.63 | 54.93 | 56.87 | 57.30 | 56.97 | 59.63 | 57.49 | 59.73 | 58.35 | 58.20 | 62.25 |
| Operating Income | 108 | 169 | 265 | 297 | 290 | 291 | 304 | 291 | 332 | 332 | 364 | 376 | 330 |
| Change (%) | 56.48 | 57.16 | 11.76 | -2.09 | 0.25 | 4.54 | -4.45 | 14.02 | -0.01 | 9.83 | 3.20 | -12.09 | |
| % of Revenue | 26.50 | 36.37 | 43.37 | 45.07 | 43.13 | 42.70 | 43.03 | 40.37 | 42.51 | 40.27 | 41.65 | 41.80 | 37.75 |
| Interest Expense | -8 | -12 | -16 | -15 | -15 | -15 | -15 | -16 | -17 | -18 | -18 | -19 | -20 |
| Change (%) | 36.73 | 35.36 | -1.25 | -2.44 | -3.06 | 5.93 | 4.55 | 4.43 | 4.35 | 4.85 | 5.32 | 4.98 | |
| % of Revenue | -2.07 | -2.48 | -2.55 | -2.34 | -2.23 | -2.13 | -2.18 | -2.24 | -2.16 | -2.13 | -2.11 | -2.16 | -2.33 |
| Net Income | 79 | 124 | 151 | 182 | 199 | 240 | 240 | 234 | 270 | 296 | 339 | 354 | 322 |
| Change (%) | 56.59 | 21.59 | 20.48 | 9.44 | 20.60 | -0.03 | -2.42 | 15.67 | 9.32 | 14.60 | 4.64 | -9.05 | |
| % of Revenue | 19.44 | 26.69 | 24.63 | 27.59 | 29.51 | 35.15 | 33.87 | 32.45 | 34.66 | 35.90 | 38.74 | 39.42 | 36.83 |
Source: Capital IQ
